Prenatal Testing

Natera Acquires Reproductive Health Assets from Invitae

Natera has acquired certain assets from Invitae relating to its non-invasive prenatal screening and carrier screening business.

Prenatal Testing

Fetal Fraction Enrichment for NIPT

Diagnostic screening for Down’s Syndrome during pregnancy was difficult until the development of an NIPT fetal fraction test.

Prenatal Testing

Biomarkers Id’d that May Detect Pregnancy Risks Earlier

Researchers have identified biological markers that could improve blood tests of pregnant women to detect risks of pregnancy complications earlier.

Scientists Develop Blood Test to Predict Environmental Harms to Children

Feb 25, 2021 | Prenatal Testing

The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.

Sera Prognostics PreTRM Blood Test Gets CPT PLA Code

Feb 5, 2021 | Prenatal Testing

The new CPT PLA code will facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention.

Sera Prognostics, Anthem Launch Study to Improve Outcomes for Preterm Babies

Jan 5, 2021 | Prenatal Testing, Research

The PRIME study is designed to provide a blueprint for how healthcare can more effectively identify and manage high-risk pregnancies and reduce preterm birth.

Protein Linked to Gestational Diabetes

Dec 7, 2020 | Diabetes & Metabolic Diseases, Prenatal Testing, Research

A new study outlines a role for pregnancy-associated plasma protein A in gestational diabetes, with potential as a diagnostic tool and therapeutic target.

Progenity Test for Triaging Preeclampsia Passes Key Development Milestone

Nov 20, 2020 | Prenatal Testing

This proprietary test is a multi-analyte protein biomarker assay which is designed to be run from a simple blood draw.

Study: Enhanced Common Blood Test Could Predict Adverse Outcomes in Pregnancy

Oct 29, 2020 | Diabetes & Metabolic Diseases, Prenatal Testing

A blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.

Myriad’s Amplify Technology Improves Prequel NIPS Test

Aug 4, 2020 | Molecular Diagnostics, Prenatal Testing

The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.

Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia

Jul 5, 2020 | Prenatal Testing

The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.

BillionToOne Has Closed Its Follow-On Series A+ Funding Round of $15 Million

Mar 12, 2020 | Company News, Prenatal Testing

The new funding will be used to support commercial expansion of the company’s Unity prenatal screening test to all US states as well as research and development for future diagnostics.

Thermo Fisher Scientific and NX Prenatal Collaborate to Develop Fetal Health Assays

Jun 11, 2019 | Balances, Mass Spectrometry, Mass Spectrometry Instruments, Mass Spectrometry Reagents & Test Kits, Prenatal Testing, Research

Thermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.

First Customizable Noninvasive Prenatal Test for Single-Gene Disorders

May 13, 2019 | Prenatal Testing, Standards

The test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.

Prenatal Screening Identifies More Couples at Risk for Birth Defects

May 13, 2019 | Prenatal Testing, Research

The Foresight carrier screen identified 45% more couples at risk for having a child with cystic fibrosis than current guideline-based testing.

Next-Generation Multiplexing

Mar 27, 2019 | Microscopy, Prenatal Testing, Software

A novel multiplexing platform called ‘high definition polymerase chain reaction’ brings together widely used, low-cost chemistries and qPCR instrumentation with proprietary data science algorithms to enable streamlined multiplex test development and very affordable test deliverables.